Home›Anti Arrhythmics›Anti Arrhythmics + Nilotinib

Does Anti Arrhythmics Interact with Nilotinib?

Anti Arrhythmics and Nilotinib have a contraindicated drug interaction according to U.S. FDA drug labeling data. Avoid coadministration. Nilotinib is associated with clinically significant concentration-dependent QT prolongation; agents that prolong QT interval increase risk of serious arrhythmias. The mechanism involves nilotinib causes qt prolongation; concurrent qt-prolonging agents increase arrhythmia risk. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Contraindicated
Nilotinib Class
Kinase Inhibitor
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Anti Arrhythmics and Nilotinib occurs because nilotinib causes qt prolongation; concurrent qt-prolonging agents increase arrhythmia risk. Clinically, this means avoid coadministration. nilotinib is associated with clinically significant concentration-dependent qt prolongation; agents that prolong qt interval increase risk of serious arrhythmias. Because of the severity of this interaction, these medications are contraindicated — meaning they should not be taken together under any circumstances. If you are currently taking both, contact your healthcare provider immediately to discuss alternatives.

What To Tell Your Doctor or Pharmacist

If you are taking Anti Arrhythmics and your doctor is considering prescribing Nilotinib (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Anti Arrhythmics+💊 Nilotinib

Severity & Interaction Details

⛔
contraindicated
Avoid this combination
FDA labeling lists this pair as contraindicated. The risk outweighs the benefit in nearly all cases.
Severity scale
MinorContra
On record
Yes
Drug A class
—
Drug B class
Kinase Inhibitor
Source
NLP:nilotinib

What this means in plain English

Avoid coadministration. Nilotinib is associated with clinically significant concentration-dependent QT prolongation; agents that prolong QT interval increase risk of serious arrhythmias.

What the FDA label says

"Nilotinib causes QT prolongation; concurrent QT-prolonging agents increase arrhythmia risk"

📖 Source: NLP:nilotinib

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Anti Arrhythmics and Nilotinib against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.